Bath & Body Works, Inc. (NYSE:BBWI) Given Consensus Rating of “Hold” by Analysts

Shares of Bath & Body Works, Inc. (NYSE:BBWIGet Free Report) have been given a consensus recommendation of “Hold” by the eighteen analysts that are currently covering the stock, MarketBeat.com reports. Thirteen analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $22.9286.

BBWI has been the subject of a number of analyst reports. Jefferies Financial Group started coverage on Bath & Body Works in a research note on Wednesday, January 14th. They set a “hold” rating and a $24.00 target price for the company. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Deutsche Bank Aktiengesellschaft assumed coverage on Bath & Body Works in a report on Thursday, January 8th. They issued a “hold” rating and a $21.00 target price for the company. Morgan Stanley restated an “equal weight” rating and set a $18.00 target price (down from $43.00) on shares of Bath & Body Works in a research report on Friday, November 21st. Finally, UBS Group increased their price target on shares of Bath & Body Works from $17.00 to $21.00 and gave the company a “neutral” rating in a report on Thursday, January 8th.

Read Our Latest Stock Report on Bath & Body Works

Insider Activity at Bath & Body Works

In other news, Director Stephen D. Steinour acquired 6,700 shares of Bath & Body Works stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average cost of $14.86 per share, with a total value of $99,562.00. Following the completion of the acquisition, the director owned 48,175 shares in the company, valued at $715,880.50. This trade represents a 16.15% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Steven E. Voskuil bought 20,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were purchased at an average price of $15.04 per share, for a total transaction of $300,800.00. Following the completion of the transaction, the director owned 33,925 shares of the company’s stock, valued at $510,232. This represents a 143.63% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 33,513 shares of company stock valued at $500,442 in the last 90 days. Insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. American Century Companies Inc. grew its stake in Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after acquiring an additional 4,949,796 shares during the last quarter. Jupiter Asset Management Ltd. raised its position in Bath & Body Works by 553.2% during the third quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock worth $95,685,000 after acquiring an additional 3,145,797 shares during the last quarter. Norges Bank purchased a new stake in shares of Bath & Body Works in the fourth quarter valued at about $55,504,000. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of Bath & Body Works in the third quarter valued at approximately $43,113,000. Finally, Cooper Creek Partners Management LLC increased its stake in shares of Bath & Body Works by 42.7% during the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock worth $162,081,000 after purchasing an additional 1,619,276 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Key Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

  • Negative Sentiment: Multiple law firms have either filed or are soliciting plaintiffs in a securities class action against Bath & Body Works alleging violations of Sections 10(b) and 20(a) and Rule 10b‑5, covering purchases between June 4, 2024 and November 19, 2025; lead‑plaintiff deadlines are being advertised around March 13–16, 2026. These notices signal active litigation and potential future settlement or judgment exposure. DJS Law Group Notice Rosen Law Firm Notice Kessler Topaz Notice

Bath & Body Works Stock Performance

BBWI stock opened at $24.07 on Tuesday. The stock has a market capitalization of $4.93 billion, a PE ratio of 7.41, a price-to-earnings-growth ratio of 1.06 and a beta of 1.54. The company has a fifty day moving average of $21.44 and a 200-day moving average of $24.01. Bath & Body Works has a one year low of $14.27 and a one year high of $41.87.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The company’s revenue was down 1.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. Equities analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Shareholders of record on Friday, February 20th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 20th. This represents a $0.80 dividend on an annualized basis and a yield of 3.3%. Bath & Body Works’s dividend payout ratio (DPR) is 24.62%.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Recommended Stories

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.